ELOXX PHARMACEUTICALS, INC. Debt Conversion, Converted Instrument, Amount
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Debt Conversion, Converted Instrument, Amount of $3.17 million for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2020-03-06
- ELOXX PHARMACEUTICALS, INC. debt conversion, converted instrument, amount for the quarter ending 2017-12-31 was $0.00.
- ELOXX PHARMACEUTICALS, INC. debt conversion, converted instrument, amount for the quarter ending 2017-09-30 was $2.20M.
- ELOXX PHARMACEUTICALS, INC. debt conversion, converted instrument, amount for the quarter ending 2016-09-30 was $0.00.
- ELOXX PHARMACEUTICALS, INC. debt conversion, converted instrument, amount for fiscal 2017 was $3.17M.
- ELOXX PHARMACEUTICALS, INC. debt conversion, converted instrument, amount for fiscal 2017 was $268.38K.
- ELOXX PHARMACEUTICALS, INC. debt conversion, converted instrument, amount for fiscal 2016 was $0.00.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $2.20M derived: sum of 2 quarters · filed 2020-03-06 | $3.17M 10-K · filed 2020-03-06 | |
| 2017-09-30 | $2.20M 10-Q · filed 2017-11-14 | $3.17M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $3.17M 10-Q · filed 2018-08-10 | $268.38K 10-K · filed 2017-10-13 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | $0.00 10-K · filed 2017-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |